<DOC>
	<DOC>NCT02221141</DOC>
	<brief_summary>The purpose of this study is to determine the prevalence in Belgium of Fabry disease in patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to determine in Fabry patients which was the most frequently initial symptom. Actually the early diagnosis is important because a treatment exists that can prevent future complications.</brief_summary>
	<brief_title>Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography</brief_title>
	<detailed_description />
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy, Left Ventricular</mesh_term>
	<criteria>unexplained left ventricular hypertrophy isolated septal hypertrophy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>